Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9NJ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,074
Award facts
- Contract value 100% obligated
- $42,073.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency awarded a delivery order valued at $42,073.95 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/ml SureClick auto-injectors. The contract, which is not set aside and competitively awarded, represents a firm fixed-price delivery order with an ultimate completion date of January 29, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this delivery order as a child contract under its parent organization Cencora, Inc. (doing business as AmerisourceBergen). This award is issued under a larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply agreement for military healthcare systems worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of pharmaceutical product deliveries through the DLA Medical Supply Chain. The broader IDC encompasses a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for ENBREL, a prescription medication commonly used for rheumatoid arthritis and other autoimmune conditions, reflects the company's continued role in supporting military healthcare programs and the Defense Health Agency's medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F9NJ7?
SPE2DR26F9NJ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9NJ7 worth?
The government has obligated $42,074 on SPE2DR26F9NJ7.
Is contract SPE2DR26F9NJ7 an order under another contract?
Yes. SPE2DR26F9NJ7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NJ7 competed?
The extent of competition for SPE2DR26F9NJ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award